Compare IVVD & EQBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IVVD | EQBK |
|---|---|---|
| Founded | 2020 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 692.7M | 800.2M |
| IPO Year | 2021 | 2015 |
| Metric | IVVD | EQBK |
|---|---|---|
| Price | $2.22 | $44.59 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 6 |
| Target Price | $8.33 | ★ $47.80 |
| AVG Volume (30 Days) | ★ 11.9M | 65.3K |
| Earning Date | 11-06-2025 | 01-21-2026 |
| Dividend Yield | N/A | ★ 1.64% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.00 |
| Revenue | $50,039,000.00 | ★ $186,035,000.00 |
| Revenue This Year | $103.88 | $15.54 |
| Revenue Next Year | $171.40 | $37.88 |
| P/E Ratio | ★ N/A | $43.83 |
| Revenue Growth | ★ 332.71 | 17.93 |
| 52 Week Low | $0.35 | $34.11 |
| 52 Week High | $3.07 | $49.05 |
| Indicator | IVVD | EQBK |
|---|---|---|
| Relative Strength Index (RSI) | 53.88 | 70.03 |
| Support Level | $2.09 | $43.35 |
| Resistance Level | $2.60 | $43.94 |
| Average True Range (ATR) | 0.25 | 1.01 |
| MACD | -0.02 | 0.28 |
| Stochastic Oscillator | 41.67 | 96.74 |
Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.
Equity Bancshares Inc is a bank holding company. It provides a broad range of financial services to businesses and business owners as well as individuals through network of nearly 71 branches located in Arkansas, Kansas, Missouri and Oklahoma. The majority of the Company's revenues come from interest income on financial instruments, including loans, leases, securities and derivatives. The company also earns revenue from Non-interest income which includes Service charges and fees, Debit card income, Investment Referral Income, Trust Income and Insurance Sales Commissions.